Literature DB >> 22261085

Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer.

J L Dikken1, N C T van Grieken, P Krijnen, M Gönen, L H Tang, A Cats, M Verheij, M F Brennan, C J H van de Velde, D G Coit.   

Abstract

BACKGROUND: While it is suggested that more than 15 lymph nodes (LNs) should be evaluated for accurate staging of gastric cancer, LN yield in western countries is generally low. The effect of preoperative chemotherapy on LN yield in gastric cancer is unknown. The aim of the present study is to determine whether preoperative chemotherapy is associated with any difference in the number of LNs obtained from specimens of patients who underwent curative surgery for gastric adenocarcinoma. PATIENTS AND METHODS: In 1205 patients from Memorial Sloan-Kettering Cancer Center (MSKCC) and 1220 patients from the Netherlands Cancer Registry (NCR) who underwent a gastrectomy with curative intent for gastric adenocarcinoma without receiving preoperative radiotherapy, LN yield was analyzed, comparing patients who received preoperative chemotherapy and patients who received no preoperative therapy.
RESULTS: Of the 2425 patients who underwent a gastrectomy, 14% received preoperative chemotherapy. Median LN yields were 23 at MSKCC and 10 in the NCR. Despite this twofold difference in LN yield between the two populations, with multivariate Poisson regression, chemotherapy was not associated with LN yield of either population. Variables associated with increased LN yield were institution, female sex, lower age, total (versus distal) gastrectomy and increasing T-stage.
CONCLUSIONS: In this patient series, treatment at MSKCC, female sex, lower age, total gastrectomy and increasing primary tumor stage were associated with a higher number of evaluated LNs. Preoperative chemotherapy was not associated with a decrease in LN yield. Evaluating more than 15 LNs after gastrectomy is feasible, with or without preoperative chemotherapy.
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22261085     DOI: 10.1016/j.ejso.2011.12.016

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Authors:  Naruhiko Ikoma; Jeannelyn S Estrella; Wayne L Hofstetter; Jaffer A Ajani; Keith F Fournier; Paul F Mansfield; John M Skibber; Brian D Badgwell
Journal:  J Gastrointest Surg       Date:  2018-07-27       Impact factor: 3.452

2.  Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.

Authors:  Theresa L A Jeuck; Christian Wittekind
Journal:  Gastric Cancer       Date:  2014-02-19       Impact factor: 7.370

3.  Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial.

Authors:  Jennifer Straatman; Nicole van der Wielen; Miguel A Cuesta; Suzanne S Gisbertz; Koen J Hartemink; Alfredo Alonso Poza; Jürgen Weitz; Fransico Mateo Vallejo; Khurshid Ahktar; Ismael Diez Del Val; Josep Roig Garcia; Donald L van der Peet
Journal:  Trials       Date:  2015-03-27       Impact factor: 2.279

4.  Safety and feasibility of minimally invasive gastrectomy during the early introduction in the Netherlands: short-term oncological outcomes comparable to open gastrectomy.

Authors:  H J F Brenkman; J P Ruurda; R H A Verhoeven; R van Hillegersberg
Journal:  Gastric Cancer       Date:  2017-02-09       Impact factor: 7.370

5.  Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.

Authors:  Shiela S Macalindong; Kwang Hee Kim; Byung-Ho Nam; Keun Won Ryu; Norihito Kubo; Ja Yeon Kim; Bang Wool Eom; Hong Man Yoon; Myeong-Cherl Kook; Il Ju Choi; Young Woo Kim
Journal:  BMC Cancer       Date:  2018-01-12       Impact factor: 4.430

6.  Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.

Authors:  Harsh Kanhere; Raghav Goel; Ben Finlay; Markus Trochsler; Guy Maddern
Journal:  Int J Surg Oncol       Date:  2018-01-14

7.  Lymph Node Yield Following Packet Submission After Isolation By Surgeon During Gastrectomy.

Authors:  Pengpeng Wang; Kecheng Zhang; Hongqing Xi; Wenquan Liang; Tianyu Xie; Yunhe Gao; Bo Wei; Lin Chen
Journal:  Cancer Manag Res       Date:  2019-11-19       Impact factor: 3.989

8.  Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial.

Authors:  Nicole van der Wielen; Jennifer Straatman; Freek Daams; Riccardo Rosati; Paolo Parise; Jürgen Weitz; Christoph Reissfelder; Ismael Diez Del Val; Carlos Loureiro; Purificación Parada-González; Elena Pintos-Martínez; Francisco Mateo Vallejo; Carlos Medina Achirica; Andrés Sánchez-Pernaute; Adriana Ruano Campos; Luigi Bonavina; Emanuele L G Asti; Alfredo Alonso Poza; Carlos Gilsanz; Magnus Nilsson; Mats Lindblad; Suzanne S Gisbertz; Mark I van Berge Henegouwen; Uberto Fumagalli Romario; Stefano De Pascale; Khurshid Akhtar; H Jaap Bonjer; Miguel A Cuesta; Donald L van der Peet
Journal:  Gastric Cancer       Date:  2020-07-31       Impact factor: 7.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.